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Objective: To assess the effects of fish (lean or oily) and fish oil consumption on blood lipid concentration during weight loss.
Design: Randomized, controlled 8-week trial of energy-restricted diet varying in fish and fish oil content. Subjects, 324 men and
women, aged 20–40 years, body mass index 27.5–32.5 kg m2, from Iceland, Spain and Ireland, were randomized to one
of four groups: (1) control (sunflower oil capsules, no seafood), (2) cod diet (3 150 g week1), (3) salmon diet
(3150 g week1), (4) fish oil (DHA/EPA capsules, no seafood). The macronutrient composition of the diets was similar
between the groups and the capsule groups were single-blinded.
Measurements: Total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein cholesterol, triacylglycerol
(TG) and anthropometrics were measured at baseline and end point.
Results: The difference in logTG lowering between the control group and the cod diet, salmon diet and fish oil from baseline
to end point was 0.036 (95% CI 0.079 to 0.006), 0.060 (0.101 to 0.018) and 0.037 (0.079 to 0.006), respectively.
Reduction in TC was about 0.2 mmol l1 greater in the fish groups (cod and salmon) than in the control group, but only of
borderline significance when adjusting for weight loss. HDL tended to decrease less in the diet groups consuming a significant
amount of n-3 fatty acids (salmon and fish oil).
Conclusion: Weight-loss diet including oily fish resulted in greater TG reduction than did a diet without fish or fish oil.
Controlled trials using whole fish as a test meal are encouraged to be able to elucidate the role of different constituents of fish for
human health.
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Introduction
It is well known that excessive body weight increases the
risk of developing a number of serious diet-related chronic
illnesses, including cardiovascular diseases. In this context,
countries with high fish intake have been shown to have
lower rates of coronary heart disease, compared with other
countries.1–3
Studies testing the effects of fish as food in combination
with weight loss are scarce.4,5 Long-chain n-3 poly-unsatu-
rated fatty acids (LC n-3 PUFAs), given as supplements, have
in recent trials been shown to have beneficial effects on
cardiovascular disease risk factors as an additional therapy to
calorie restriction in overweight and obese individuals.6–8
The triacylglycerol (TG) lowering effects of n-3 fatty acids are
well documented,9 and the beneficial effects of fish intake
seen on blood lipids in previous trials have primarily been
attributed to the presence of n-3 fatty acids. The role of other
seafood constituents, such as fish proteins, has been studied
in animals.10–12 Hypocholesterolemic effects of fish proteins
have been reported in animals together with lower hepatic
TG concentration.13 Very few human trials have addressed
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this issue,14 and studies on the effects of lean fish intake in
comparison with oily fish intake on blood lipids during
weight loss are very limited.15
Emphasis should be on obesity prevention in children not
only to prevent serious consequences of overweight and
obesity, but also to study effects of different weight loss diets
especially among young people. In this perspective, known
risk factors for chronic diseases often associated with over-
weight and obesity should also be assessed. By means of a
randomized controlled trial in three European countries, the
aim of this study was to investigate the specific effects of
seafood consumption on blood lipids during weight loss
induced by an energy-restricted diet in young European
overweight individuals. This was done by comparing an
energy-restricted control diet, without food of marine origin,
with energy-restricted diets including either fish or fish oil,
all similar in composition with regard to total fat, protein
and carbohydrate content.
Subjects and methods
The study was a randomized 8-week intervention trial of four
energy-restricted diets in three European countries: Iceland,
Spain and Ireland. The study is part of a large multi-centre
study, funded by the European Union: SEAFOODplusFa
better life with seafood.
Participants
Subjects were recruited through advertisements. The enrol-
ment of 320 subjects (140 from Iceland, 120 from Spain and
60 from Ireland) was planned. Initially 324 subjects (138
men and 186 women) were included. The Icelandic and Irish
subjects were of Caucasian origin and the Spanish partici-
pants were Hispanic. The inclusion criteria were body mass
index 27.5–32.5 kg m2, age 20–40 years and waist circum-
ference of X94 and X80 cm for men and women, respec-
tively. Participants were students at the local universities and
employees at major companies and institutions in Reykjavik,
Cork and Pamplona. Majority of the subjects were married or
in common-law marriage (Table 2), and 60–80% of subjects
were studying in universities, had a university degree or
higher education. Exclusion criteria were weight change due
to weight-loss diet within 3 months before the start of the
study, use of supplements containing n-3 fatty acids, calcium
or vitamin-D during the last 3 months, drug treatment of
diabetes mellitus, hypertension or hyperlipidemia and
women’s pregnancy or lactation. Recruitment was under-
taken in 2004 and 2005. The study was approved by the
National Bioethical Committee in Iceland (04-031), the
Ethical Committee of the University of Navarra in Spain
(24/2004) and the Clinical Research Ethics Committee of the
Cork University Hospital in Ireland. The study followed the
Helsinki guidelines, and all subjects participating gave their
written consent before the start.
Protocol
The subjects made at least three visits to the nutrition unit
during the 8-week trial, at baseline, midpoint and end point.
Additionally, they were contacted on at least two other
occasions by phone and/or email, in weeks two and six. At
baseline, midpoint and end-point visits, they met a dietician,
anthropometrical measurements were performed and sea-
food intake was assessed by a validated food frequency
questionnaire described elsewhere.16 Dietary intake was
assessed by 2-day weighed food records before baseline
(habitual diet) and in week six or later during the two last
weeks of the intervention trial. At baseline, information on
physical activity patterns during the last year, smoking
habits, alcohol consumption and use of contraceptive
therapy was collected using a questionnaire. Subject’s
physical activity level was assessed at baseline and end point
and subjects were instructed not to change their physical
activity levels. Subjects were instructed to keep their alcohol
consumption to a minimum. The dietary records were
analysed using the food-nutrient database in each country.
Compliance to the diets was assessed by the 2-day weighed
food records, by the validated food frequency questionnaire
and by analysing n-3 and n-6 fatty acids in erythrocyte
phospholipids in fasting blood samples from the subjects.
Randomization and control group (placebo)
After baseline experimentation, each volunteer was ran-
domly assigned to one of the four experimental diets (1:
control, 2: cod (lean white fish), 3: salmon (oily fish), 4: fish
oil). The randomization list was computer generated (SPSS
programme) by the Icelander partner. In each country, the
research dietician/nutritionist assigned the randomization
number to each subject enrolled into the trial. People
following the control and fish oil diets were single-blind
supplemented every day with six sunflower oil capsules as
placebo and six fish oil capsules, respectively. Participants
were provided with cod and salmon during the trial (Table 1).
The proximate chemical composition of the fish and capsules
(Table 1) used in the study was carried out according to
Association of Analytical Communities (AOAC) methods,17
and fatty acid determination followed the conditions described
previously by Bandarra et al.18 Absolute values were calculated
using the correction factors proposed by Weihrauch et al.19
Intervention diets
Basal metabolic rate was estimated by applying Harris–
Benedict equations,20 and a correction factor due to the
overweight status of the subjects.21,22 Ideal body weight
was calculated from the following formula: ideal body
weight¼50þ (0.75 (height150). The weight that was
used in the HB equation was then calculated: ((actual
weightideal body weight)0.25)þ ideal body weight. To
estimate total energy expenditure, the physical activity level
was set according to low physical activity level as reported by
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subjects.23 Subjects were instructed to follow a diet, energy-
restricted by 30% from the estimated energy expenditure
(approximately 600 kcal day1), for 8 consecutive weeks. All
four diets were designed to provide 30% of total energy from
fat, 50% from carbohydrates, 20% of total energy from
proteins and dietary fibre (20–25 g day1). Each subject got a
detailed diet plan, menus and an exchange system to follow
for 8 weeks along with detailed instructions from the
dieticians/nutritionists to minimize difference between diets
in sources of fat (subjects were instructed to use only olive oil
and no other oil during the trial), fruit and vegetable
consumption and meal frequency. Subjects in the fish groups
(cod and salmon) were encouraged to bake the fish rather
broiling or frying and were provided with recipes appropriate
to their estimated energy level.
Serum lipids
Blood sampling (after overnight fasting) was conducted at
clinical settings in each centre. Chemical analysis was
performed centrally. Total cholesterol (TC) and TG were
analysed using an enzymatic colorimetric assay from Roche
automated clinical chemistry analyser ‘Hitachi 911’, high-
density lipoprotein cholesterol (HDL-C) was determined
directly in serum, using poly-ethylene glycol-modified
enzymes and dextrane sulphate. Levels of low-density
lipoprotein cholesterol (LDL-C) were calculated using the
Friedwald formula.
Anthropometrical measurements
Anthropometrical measurements were performed on three
occasions during the 8-week period: at baseline, midpoint
and endpoint. Weight was measured in light underwear on a
calibrated scale (SECA 708, Hamburg, Germany) in all
centres. Subject’s height was measured with a calibrated
stadiometer, and waist circumference was measured, using
an inelastic measuring tape, following standard methods.24
All measurements were done using standard measurement
procedures as outlined in a research protocol used by all
countries participating in the study.
Statistical analysis
The individuals included in the study were young and
healthy individuals, except for their being overweight or
obese, so a normal model was a natural candidate. With 65
subjects per group (assuming 20% drop-out rate), the study
was powered to detect 0.3 s.d. difference in outcome
variables at 80% power. In the initial descriptive approach,
some univariate models were estimated. Some two-way
interactions were tested but they were not significant. The
dependent variables were TC, HDL-C, LDL-C and logTG. Two
linear models were applied:
D¼ y at baselineþ genderþ countryþ dietary groups ð1Þ
D ¼ y at baseline þ genderþ countryþ dietary groups
þ Dweight ð2Þ
The y variables were TC, HDL-C, LDL-C and logTG. Serum TG
concentration was transformed before analysis to reduce
skewness in the distribution. Traditional residual diagnosis
was performed. The drop-out process was modelled with a
binary response model. The impact of the covariates on the
probability of dropout was evaluated by a logistic regression.
Results
Baseline characteristics and dropouts
Of the 324 randomized individuals entering the trial,
measurements of blood concentration at end point were
available for 262 individuals (80%). The flow of participants
in the study is shown in Figure 1. The two commonest
reasons for dropout were that the subject was unable to
follow the prescribed diet and/or lack of time to maintain the
Table 1 Description of the intervention diets and the n-3, EPA, DHA and n-6 intake attributable to the fish and capsules used in the different diets (mg day1)a
Diet groups Amount consumed per day n-3 fatty acids
(mg day1)a
EPA
(mg day1)a
DHA
(mg day1)a
n-6 fatty acids
(mg day1)a
Manufacturer
Control Six placebo (sunflower oil)
capsules per day
6±0.2 ND ND 336± 5 Loders Croklaan (Lipid Nutrition),
Wormerveer, The Netherlands
Encapsulated by Banner
Pharmacaps,
Tilburg, The Netherlands)
Cod 150 g cod three times per week 272±3 54±7 207±12 17±1 Samherji, Iceland
Salmon 150 g salmon three times per week 3004±129 774±29 1370±88 665±20 Marine Harvest, Nutreco, Norway
Fish oil Six fish oil capsules per day 1418±34 633±9 430±9 124±3 Loders Croklaan (Lipid Nutrition),
Wormerveer, The Netherlands.
Encapsulated by Banner
Pharmacaps,
Tilburg, The Netherlands
Abbreviation: ND, not detected. aCalculated from fatty acid analysis of samples of fish and capsules (n¼8 for each diet). Each subject was instructed to follow a diet,
energy-restricted by 30% from estimated energy expenditure. All four diets were designed to provide 30% of total energy from fat, 50% from carbohydrates, 20% of
total energy from proteins and dietary fibre 20–25 g day1.
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schedule of clinical visits. Dropouts were equally distributed
between intervention diet groups, and variables predicting
weight loss or changes in any of the blood parameters
measured were not different between dropouts and those
who completed the trial. The results of the logistic regression
suggest no systematic explanation of dropping out. The
baseline characteristics of the subjects are shown in Table 2.
The average energy intake of subjects before randomization
was 2322 kcal day1 where protein, fat and carbohydrates
contributed to 17%, 36% and 42% of the total energy intake,
respectively. Frequency of fish consumption at baseline was
five (median) times per month as main meal and five times
per month as bread spread or side dish. No differences were
seen between the diet groups in terms of energy intake,
distribution of energy-giving nutrients or frequency of fish
consumption at baseline.
Weight loss and unadjusted decrease in blood lipid
concentration
The average weight loss was 6.5 kg (s.d.¼ 3.3 kg) for men
and 4.2 kg (s.d.¼2.4 kg) for women. This weight loss was in
agreement with what could be expected from the prescribed
energy intake during the trial, showing good compliance to
the dietary advice. The control group lost on average about
1 kg less weight during the 8-week period than did the
groups receiving fish or fish oil (cod diet, salmon diet and
fish oil diet). The results on weight loss have been reported
in detail elsewhere.25 The 2-day food record, food frequency
questionnaire and the analysis of fatty acid profile in
erythrocytes confirmed good compliance to the diets with
324 randomized 
80 assigned to  
control group (1) 
19 dropped out 
80 assigned to  
cod diet  (2) 
13 dropped out 
84 assigned to  
salmon diet (3) 
12 dropped out 
80 assigned to  
fish oil diet (4) 
18 dropped out 
Bloodsamples
at endpoint 
obtained from 
61 in control 
group (1) 
Bloodsamples
at endpoint 
obtained from 
67 in cod 
group (2) 
Bloodsamples
at endpoint 
obtained from 
72 in salmon 
group (3) 
Bloodsamples
at endpoint 
obtained from 
62 in fish oil 
group (4) 
Figure 1 Flow of participants in the study.
Table 2 Baseline characteristics
Women (%) Control diet Cod diet Salmon diet Fish oil diet
N Mean s.d. N Mean s.d. N Mean s.d. N Mean s.d.
60 56 50 63
Current smokers (%) 20 23 28 20
Married or in common-law marriage (%) 86 71 72 78
Age (years) 80 32.1 5.3 80 31.3 5.7 84 31.3 5.3 80 31.0 5.3
Weight at baseline (kg) 80 87.7 10.1 80 89.5 9.4 84 90.4 11.4 80 85.0 9.4
Height at baseline (m) 80 1.71 0.09 80 1.72 0.08 84 1.72 0.09 80 1.69 0.09
BMI (kg m2) 80 30.0 1.5 80 30.2 1.4 84 30.4 1.4 80 29.9 1.5
Waist circumference (cm) 80 95.2 7.4 80 96.8 6.7 84 96.9 7.9 80 94.0 6.7
Triacylglycerol (mmol l1) 76 1.07 0.59 79 1.31 0.73 80 1.18 0.52 79 1.15 0.73
Cholesterol (mmol l1) 76 5.07 0.87 79 5.26 1.04 80 5.07 0.88 79 4.95 0.95
HDL-cholesterol (mmol l1) 76 1.39 0.36 79 1.32 0.30 80 1.34 0.44 79 1.38 0.32
LDL cholesterol (mmol l1) 76 3.19 0.74 79 3.37 0.96 80 3.19 0.80 79 3.05 0.87
Table 3 Mean change (unadjusted) in weight and blood lipids from baseline
to end point in the 8-week trial
Control diet Cod diet Salmon diet Fish oil diet
Mean s.d. Mean s.d. Mean s.d. Mean s.d.
Weight (kg) 4.37 2.80 5.35 2.74 5.48 3.32 5.38 3.23
Total cholesterol
(mmol l1)
0.25 0.71 0.54 0.75 0.48 0.62 0.32 0.63
LDL (mmol l1) 0.19 0.56 0.34 0.66 0.33 0.56 0.15 0.57
HDL (mmol l1) 0.04 0.23 0.09 0.17 0.03 0.19 0.08 0.19
Triglycerides
(mmol l1)
0.04 0.45 0.28 0.51 0.26 0.44 0.20 0.61
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regard to energy intake, fish consumption and distribution
of energy-giving nutrients. Physical activity level of subjects
did not change during the trial.25 The average weight loss
and unadjusted decrease in blood lipid concentration during
the 8-week trial can be seen in Table 3.
Linear models
In all models estimated, the impact of serum lipids reduction
was greater in individuals with high serum concentrations at
baseline. Baseline concentration was therefore accounted for
in all linear models. Changes in body weight during the trial
also strongly predicted reduction in blood lipids. The control
group lost on average about 1 kg less weight than the other
groups. Owing to difference in weight loss between dietary
groups, we chose to show the estimates both including and
excluding weight loss from the models. Table 4 shows the
change in serum lipid concentrations in each dietary group
when compared with the control group.
Triacylglycerol
The most significant diet group effect was seen for serum TG.
When compared with the control group, the groups receiving
the cod diet, salmon diet or fish oil experienced greater
reduction in TG concentration (expressed as logTG in
Table 4). The cod diet (lean fish) lowered TG to a similar
degree as fish oil diet. Interestingly, when including weight
loss in the models, it attenuated the estimates for diet group
effects only to a minor degree but resulted in a non-
significant difference from control for the group receiving
cod and fish oil. No significant country effects were
observed. A small gender effect was seen, where the TG-
lowering effect of the weight-loss diets seemed slightly
greater in women than men (adjusted for baseline values
and weight loss; data not shown).
Total cholesterol
As seen in Table 4, the reduction in TC was greater in the
groups receiving fish (cod or salmon), but not in the fish oil
group, compared with the control group, although this
difference did not reach statistical significance in model 2
(Table 4) when adjusting for weight loss during the trial.
During the 8-week intervention, 1 mmol l1 higher baseline
value for TC resulted in 0.28 mmol l1 (95% CI 0.21–0.36)
greater TC reduction. No significant country- or gender-
specific effects were observed.
LDL and HDL cholesterol
As seen in Table 4, the cholesterol-lowering effect of the cod
diet is partly because of lowering of HDL-C rather than
LDL-C, in comparison with the other dietary groups.
However, the estimates for LDL tended to be greater in the
groups receiving cod or salmon, suggesting that part of the
Table 4 Difference in blood lipid concentration between the control group (receiving no fish or fish oil, only placebo capsules) and the other three dietary groups
(cod diet, salmon diet and fish oil diet) assessed by general linear modelsa,b
Model 1a Difference from
control group
95% CI Model 2b Difference from
control group
95% CI
Lower Upper P Lower Upper P
Total cholesterol (mmol l1) Total cholesterol
Cod diet 0.243 0.448 0.038 0.021 Cod diet 0.164 0.352 0.024 0.087
Salmon diet 0.235 0.438 0.032 0.024 Salmon diet 0.150 0.337 0.037 0.117
Fish oil diet 0.106 0.313 0.101 0.317 Fish oil diet 0.024 0.166 0.214 0.803
LDL cholesterol (mmol l1) LDL cholesterol
Cod diet 0.110 0.289 0.070 0.231 Cod diet 0.065 0.238 0.107 0.458
Salmon diet 0.134 0.312 0.044 0.141 Salmon diet 0.079 0.251 0.092 0.365
Fish oil diet 0.005 0.177 0.186 0.961 Fish oil diet 0.057 0.117 0.232 0.521
HDL cholesterol (mmol l1) HDL cholesterol
Cod diet 0.072 0.132 0.012 0.019 Cod diet 0.061 0.119 0.002 0.044
Salmon diet 0.011 0.071 0.048 0.711 Salmon diet 0.001 0.057 0.059 0.970
Fish oil diet 0.047 0.108 0.013 0.124 Fish oil diet 0.037 0.096 0.022 0.222
HDL/CH (ratio) HDL/CH
Cod diet 0.003 0.016 0.011 0.692 Cod diet 0.005 0.008 0.018 0.476
Salmon diet 0.011 0.002 0.024 0.094 Salmon diet 0.009 0.004 0.022 0.183
Fish oil diet 0.005 0.019 0.008 0.458 Fish oil diet 0.007 0.006 0.021 0.273
logTG (mmol l1) logTG
Cod diet 0.046 0.090 0.003 0.038 Cod diet 0.036 0.079 0.006 0.092
Salmon diet 0.071 0.114 0.028 0.001 Salmon diet 0.060 0.101 0.018 0.005
Fish oil diet 0.047 0.091 0.003 0.035 Fish oil diet 0.037 0.079 0.006 0.090
aModel 1. Variables included are blood lipid concentration at baseline, gender and country. bModel 2. Variables included are blood lipid concentration at baseline,
gender, country and weight loss during the 8-week trial.
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reduction in TC seen in these two groups could be
attributable to reduction in LDL-C. HDL-C concentration
tended to decrease less in the diet groups consuming a
significant amount of LC n-3 PUFAs. No difference was
observed between groups in the ratio between HDL-C and
TC. A country-specific effect was observed for LDL-C in the
model: participants in Spain tended to lower their LDL-C
cholesterol 0.16 mmol l1 (95% CI 0.02–0.30) more than
participants in Iceland, adjusted for total weight loss. No
gender-specific effect was observed, whereas for HDL-C, no
significant country- or gender-specific effect was seen.
Other possible confounding factors
In the linear models presented in Table 4, adjustments were
made for baseline concentration of each blood lipid,
country, gender and weight loss. Adjustments for other
possible confounding factors such as frequency of habitual
fish intake or fatty acid profile (% DHA) in erythrocytes at
baseline (as an indicator of habitual fish intake), smoking
habits, alcohol consumption or contraceptive therapy did
not change the findings presented in Table 4, as these factors
were equally distributed between the four groups.
Discussion
Inclusion of oily fish in an energy-restricted weight-loss diet
among young overweight or obese individuals resulted in
greater reduction in TG concentration when compared with
a group receiving diet without food of marine origin.
Lowering of TC was observed in the fish groups, both cod
and salmon, although not statistically significant after
adjusting for weight loss during the trial. Reduction of TC
observed in the group receiving cod diet (lean fish) was
partly because of reduction in HDL-C, receiving relatively
low amounts of LC n-3 PUFAs.
Overweight and obesity are increasing around the world
and it is therefore very important to study whether different
food items in calorie-restricted diets could have different
effects on risk factors for chronic diseases during weight loss.
This study was designed to assess the effects of inclusion or
exclusion of food of marine origin to weight-loss diet.
During the past 20 years, several studies have implicated
the beneficial health effects of fish consumption.1–3 These
findings are additionally supported by two recent meta-
analyses suggesting that fish intake may be an important
component for the prevention of coronary heart disease.26,27
There are many properties in fish that may protect against
coronary heart disease,28 LC n-3 PUFAs being the most
frequently involved. LC n-3 PUFAs have been shown to
protect against arrhythmia, reduce platelet aggregation and
thereby have an anti-thrombotic effect, reduce inflamma-
tory mediators and also to lower triacylglycerol in the
blood.29–33 However, the benefits of LC n-3 PUFAs on
cardiovascular health are still a matter of debate.34
The TG-lowering effects of LC n-3 PUFAs are well
documented.9,35,36 The hypotriacylglycerolemic effects of
LC n-3 PUFAs were apparent in this study, where the greatest
reduction in TG concentration was seen in the group
receiving the largest amount of LC n-3 PUFAs. The salmon
was estimated to provide around 2 g DHA and EPA per day,
compared with 1 g day1 in the amount of fish oil provided,
and 150 g of cod eaten three times per week provided about
0.26 g day1 of DHA and EPA (see Table 1). The fall in TG in
the salmon group and the fish oil group is therefore in
agreement with the extensive literature on the TG-lowering
effects of LC n-3 PUFAs and results from recent trials,
showing beneficial effects of LC n-3 PUFA supplementation
on cardiovascular risk factors during weight loss.6–8 How-
ever, TG-lowering effect of the lean cod diet shown in this
study has not been seen previously in a human study. The
different components of fish contributing to cardiovascular
health have been assessed in the rat, where cod protein has
been shown to lower hepatic TG concentration and TG
secretion rate when compared with casein.13 In a recent
human trial by Moore et al.,15 subjects received two portions
of oily fish (on average 0.65 g day1 DHA and EPA) or white
fish (on average 0.1 g day1 DHA and EPA), in combination
with either high or low linoleic acid: a-linolenic acid ratio.
Dietary intervention by white fish (lean fish) resulted in
higher TG levels than the oily fish. It might therefore be
suggested that the TG-lowering effect of the cod diet in this
trial might be due to the LC n-3 fatty acid content of the diet
(0.26 g day1 DHA and EPA, by consumption of three 150 g
cod meals per week) rather than the fish proteins. However,
it cannot be ruled out that the interaction of n-3 fatty acids
and proteins (or other nutrients found in whole fish) might
be of importance, as the results of this trial suggest that
consuming lean fish (cod) three times per week could lower
TG concentration to a similar degree as 1.0 g day1 of DHA
and EPA taken as supplements. Controlled trials using whole
fish as a test meal are encouraged to be able to elucidate the
role of different constituents of fish for human health.
A recent systematic review on the effects of LC n-3 PUFAs
on serum markers of cardiovascular disease risk show that
the net effect on TC, LDL-C and HDL-C levels are small.35 In
our study, there was no indication on the cholesterol-
lowering effect of fish oil. However, in the groups receiving
fish (cod and salmon), TC tended to lower more than the
groups not receiving fish, although not statistically signifi-
cant after allowing for total weight loss. The sample size was
powered to detect a 0.3 s.d. difference in cholesterol change
between diet groups; thus the study was underpowered to
detect the 0.16 and 0.15 difference in TC between the fish
groups and the control group in model two (see Table 4). In
previous studies in rats, fish proteins have been found to
decrease plasma TC concentration in comparison with
casein.10–12 Hypocholesterolemic effect of fish protein in
rats13 has been attributed to a decrease in liver cholesterol
output into the circulation due to a stimulation of
cholesterol to bile acid conversion and to increased excretion
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of cholesterol and its metabolites into faeces37 or reduced
activity of Acyl-CoA: cholesterol acyltransferace.38 These
observations suggest that fish proteins might have cardio-
protective effect and be involved in the regulation of plasma
cholesterol. Human studies are needed.39
In this study, the cholesterol-lowering effect in the group
receiving the cod diet was at least partly because of a decrease
in HDL-C. In a recent systematic review of the literature, it
was suggested that fish oil (LC n-3 PUFAs) may be most
effective at raising (or stabilizing) HDL-C levels in people
whose HDL-C levels would otherwise decrease with time.35
The current trial showed that HDL-C tended to decrease less
in the diet groups consuming a significant amount of fish
oil. The fat content of the diets used in this study was around
30% of total energy intake. Fall in HDL-C is usual with a
low-fat diet, around or less than 30% of energy.40,41 It seems,
therefore, that LC n-3 PUFAs in combination with high-
quality fish proteins could be an additional means to
decrease cardiovascular risk during weight loss using diets
with relatively low fat content.
A constant limitation to nutrition interventions is the
difficulty to manage every single factor that could confound
the results such as variation in the choice and frequency of
fruits and vegetables, animal and vegetable sources of other
proteins and fat, amount and type of alcohol consumption
or physical activity. An attempt was made to control dietary
intake by providing menus and detailed exchange system in
this study. Compliance was verified by information on
dietary intake, weight loss and blood samples as far as
possible. Other factors such as socioeconomic status, educa-
tional level and occupation can also be predictive of the
response to a weight-loss programme. Our subjects were
highly motivated, well-educated individuals. Most of them
had in common being married or in common-law marriage,
and subjects claimed that they had good support from their
spouse.
In conclusion, oily fish incorporated to a weight-loss diet
among young overweight or obese individuals resulted in
greater reduction in TG concentration when compared with
a group receiving diet without food of marine origin. TG-
lowering effects of cod, in combination with relatively low
amount of LC n-3 PUFAs, shown in this study might be of
importance in understanding the health-related effects of
fish. Lowering of TC was also apparent in the groups
receiving whole fish. Interaction between LC n-3 PUFAs
from fish, fish proteins or other nutrients found in fish
might be of relevance. Controlled trials using whole fish as a
test meal are encouraged to be able to elucidate the role of
different constituents of fish for human health.
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